Currently, our virology pipeline focuses on the development of broad-spectrum small molecule drugs targeting coronaviruses, with indications encompassing diseases such as COVID-19 (Coronavirus Disease 2019), Severe Acute Respiratory Syndrome (SARS), and Middle East Respiratory Syndrome (MERS), as well as other epidemic diseases.